Common use of CLINICAL TRIALS; PUBLICATION OF RESULTS Clause in Contracts

CLINICAL TRIALS; PUBLICATION OF RESULTS. (a) Wyeth shall be responsible, at its own cost, for conducting and managing any clinical trials which may be required in order to obtain or maintain Product Approvals and Reimbursement Approvals in the Territory; provided that the protocols for all such clinical trials shall be subject to Biomatrix's prior written approval and Biomatrix shall have the right to audit the performance of any such clinical studies. * (b) Wyeth shall provide the completed data resulting from all clinical trials conducted in accordance with this Section 15.2 to Biomatrix, and Biomatrix shall be allowed to assist in analysis of the completed data and in preparing the final reports relating to such clinical trial data. Biomatrix and its Affiliates shall be free to use the results of any or all such clinical trials in the promotion, marketing and product licensing of Products and Extended Products outside the Territory. The results of any such studies will not be published or publicized in any way without the prior written approval of Biomatrix.

CLINICAL TRIALS; PUBLICATION OF RESULTS. 27 -27- (a) Wyeth shall be responsible, at its own cost, for conducting and managing any clinical trials which may be required in order to obtain or maintain Product Approvals and Reimbursement Approvals in the Territory; provided that the protocols for all such clinical trials shall be subject to Biomatrix's prior written approval and Biomatrix shall have the right to audit the performance of any such clinical studies. * (b) Wyeth shall provide the completed data resulting from all clinical trials conducted in accordance with this Section 15.2 16.2 to Biomatrix, and Biomatrix shall be allowed to assist in analysis of the completed data and in preparing the final reports relating to such clinical trial data. Biomatrix and its Affiliates shall be free to use the results of any or all such clinical trials in the promotion, marketing and product licensing of Products and Extended Products outside the Territory. The results of any such studies will not be published or publicized in any way without the prior written approval of Biomatrix.

CLINICAL TRIALS; PUBLICATION OF RESULTS. (a) Wyeth shall be responsible, at its own cost, for conducting and managing any clinical trials which may be required in order to obtain or maintain Product Approvals and Reimbursement Approvals in the Territory; provided that the protocols for all such clinical trials shall be subject to Biomatrix's prior written approval and Biomatrix shall have the right to audit the performance of any such clinical studies. * (b) Wyeth shall provide the completed data resulting from all clinical trials conducted in accordance with this Section 15.2 to Biomatrix, and Biomatrix shall be allowed to assist in analysis of the completed data and in preparing the final reports relating to such clinical trial data. Biomatrix and its Affiliates shall be free to use the results of any or all such clinical trials in the promotion, marketing and product licensing of Products and Extended Products outside the Territory. The results of any such studies *Confidential portions have been omitted and filed separately with the Commission. will not be published or publicized in any way without the prior written approval of Biomatrix.